Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic acid for vascular dysfunction in obesity
NCT04715022Phase 2Recruiting
- Sponsor
- University of Kansas Medical Center
- Start
- Jun 2021
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vascular dysfunction and hypertension (HTN) comparing Placebo infusion with Ascorbic acid infusion (2 arms). Primary endpoint: Efficacy of infusion of ascorbic acid (Blood Pressure) at 120 months. Started Jun 2021; status: recruiting.
02
Drugs
ascorbic acid
03
Conditions
vascular dysfunctionhypertension (HTN)
Beyond the preview
Go deeper on NCT04715022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04715022.